Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Nov 2023. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5277123019 | Amikacin liposome (as amikacin sulfate liposome) 590 mg dispersion for nebulizer vial | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5277124013 | Product containing precisely amikacin liposome (as amikacin sulfate liposome) 590 milligram/1 vial conventional release dispersion for nebulizer (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5283571015 | Amikacin liposome (as amikacin sulfate liposome) 590 mg dispersion for nebuliser vial | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Amikacin liposome (as amikacin sulfate liposome) 590 mg dispersion for nebulizer vial | Has manufactured dose form | Dispersion for nebuliser | true | Inferred relationship | Some | ||
| Amikacin liposome (as amikacin sulfate liposome) 590 mg dispersion for nebulizer vial | Has unit of presentation | Vial (unit of presentation) | true | Inferred relationship | Some | ||
| Amikacin liposome (as amikacin sulfate liposome) 590 mg dispersion for nebulizer vial | Plays role | Antibacterial therapeutic role (role) | false | Inferred relationship | Some | ||
| Amikacin liposome (as amikacin sulfate liposome) 590 mg dispersion for nebulizer vial | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Amikacin liposome (as amikacin sulfate liposome) 590 mg dispersion for nebulizer vial | Has presentation strength denominator unit (attribute) | Vial (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Amikacin liposome (as amikacin sulfate liposome) 590 mg dispersion for nebulizer vial | Is a | Product containing only amikacin liposome in pulmonary dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Amikacin liposome (as amikacin sulfate liposome) 590 mg dispersion for nebulizer vial | Has basis of strength substance (attribute) | Amikacin liposome | true | Inferred relationship | Some | 1 | |
| Amikacin liposome (as amikacin sulfate liposome) 590 mg dispersion for nebulizer vial | Has precise active ingredient | Amikacin sulfate liposome | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR